Tromsø, Norway, 5th October 2021 – ArcticZymes Technologies announces the availability of four advanced prototype enzymes to support the development of molecular assay kits
ArcticZymes´ has an ongoing program to support and drive innovation in molecular diagnostics and research applications. We want to share four novel enzymes to support Next Generation Sequencing (NGS) library preparation and isothermal amplification methods in assay development and point-of-care.
DUAL SPLINT LIGASE
Ligase with novel specificity enabling the ligation of DNA to both ends of RNA using a DNA splint.
HEAT-TOLERANT DUPLEX-SPECIFIC NUCLEASE
Recombinant HT-dsDNase for signal amplification in the detection of miRNA and RNA viruses.
HIGH QUALITY REVERSE TRANSCRIPTASE*
MMLV-RT for RT-qPCR and RT-LAMP.
HIGH CONCENTRATION ISOPOL™ BST+ DNA POLYMERASE
IsoPol BST+ Glycerol FREE new pack at 400 – 700 U/µl to expedite isothermal Point-of-Care diagnostics.
ArcticZymes Technologies ASA, CEO, Jethro Holter said:
“The release of these four enzymes align with our vision to provide novel and high-quality enzymes to assay developers around the globe. It is apparent the number of assays required to meet the growing demand in infectious disease and other markets is not slowing down. The release of advanced prototypes allows our customers to get early access to our technologies prior to commercial launch.”
*Available from December 2021